search
Back to results

An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study (WalkOut)

Primary Purpose

Osteoarthritis, Pain, Arthritis

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Walking
Department of Health Physical Activity Guidelines
Sponsored by
University of Nottingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring Sedentary, Knee osteoarthritis, Knee pain, Gonarthritis, Arthritis, Walking, Pedometer, Physical Activity, Activities of Daily Function, Department of Health Physical Activity Guidelines, Improve pain, Decrease pain, Improve function, Increase function, Activity Monitoring, Monitoring, Ambulatory/instrumentation

Eligibility Criteria

45 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Following current NICE (The National Institute for Health Care Excellence) guidelines (United Kingdom) for diagnosing knee osteoarthritis:

  • Anyone over the age of 45 with painful knee/s
  • No morning stiffness or stiffness that lasts less than 30 minutes

Exclusion Criteria:

  • Exercise/activity > than current Department of Health physical activity guidelines
  • Stiffness > 30mins in the morning
  • Self-reported knee pathology (cruciate, meniscal, soft tissue, joint replacement)
  • Cardiac disease - any:

    • Acute coronary syndrome < 12 months
    • Unexplained arrhythmia
    • Angioplasty/cardiac surgery
    • Congestive Cardiac Failure
    • Valvular disease
    • Cardiomyopathy
    • Myocarditis
    • Uncontrolled Hypertension
  • Thrombolic events - any:

    • Cerebrovascular accident/transient ischaemic attack last 12 months
    • Deep vein thrombosis/pulmonary embolus last 6 months
  • Asthma/Chronic Obstructive Pulmonary Disease Peak Expiratory Flow Rate < 300L/min/frequent exacerbations
  • Anaemia Haemoglobin <90d/L
  • Mental illness/learning disabilities/terminal illness
  • Does not understand English

Sites / Locations

  • University of Nottingham

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Walking

Control

Arm Description

Randomised participants will be instructed to walk 6,000 steps per day and throughout the day for 12 weeks. Step counts will be monitored by an issued pedometer. A 12 week paper diary will be provided for daily recording of step counts.

Department of Health (United Kingdom) Physical Activity Guidelines flyer (current standard of care).

Outcomes

Primary Outcome Measures

Objective assessment of participant aerobic capacity and physical function measured in the 6 Minute Walk Test

Secondary Outcome Measures

Participant subjective opinion on their knee and associated symptoms measured by KOOS (Knee Injury and Osteoarthritis Score)
Participant subjective opinion on their knee measured by WOMAC (Western Ontario and McMaster Universities Arthritis Index) Score
Participant subjective opinion on their knee measured by OKS (Oxford Knee Score)
Pain assessed VAS (Visual Analogue Scale) for knee pain
Participant subjective opinion of their general and mental health assessed by SF36 (Short Form Health Survey)
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - 30 second chair stand test
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - 40 metre fast paced walk test
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - stair climb test
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - up and go test

Full Information

First Posted
April 15, 2016
Last Updated
July 7, 2022
Sponsor
University of Nottingham
search

1. Study Identification

Unique Protocol Identification Number
NCT02748291
Brief Title
An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study
Acronym
WalkOut
Official Title
An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
April 2016 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Nottingham

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
There are over 8.75 million people in the United Kingdom with osteoarthritis in their knees. The effect of this condition can be debilitating. Symptoms are due to wear and tear of the knee joint. Some people can suffer with knee pain and stiffness. This study will look at whether walking improves the symptoms of knee osteoarthritis. Investigators will recruit anyone with knee pain over the age of 45 years in Nottingham. Participants will undergo a full assessment by a qualified Doctor. After assessment, Participants meeting the eligibility criteria will be invited to join the study. Participants will be randomly allocated into 2 groups. One group will receive standard health and exercise advice. The other group will be allocated a walking activity. This group will undertake 6,000 walking steps each day. Participants will provide pedometers to monitor this walking activity. The effect of walking will be compared using questionnaires. These will look at pain levels, quality of life and physical activity. The participants will complete these questionnaires before the study, at the 6 week midpoint and at the end of the 12 week intervention.
Detailed Description
BACKGROUND - Over 8.75 million people in the United Kingdom have painful osteoarthritis in one or both knees and a third of people of 45 years old have sought treatment. It has been well established that physical activity in mild - moderate osteoarthritis can provide improvement in symptoms and physical function. Current research is evaluating what modality of physical activity is best to achieve these improvements. A preliminary pedometer study in 2003 demonstrated symptomatic and functional improvement in knee osteoarthritis. A recent observational study has found that increased walking activity, with 6,000 steps per day being optimal, decreased the risk of functional limitation in knee osteoarthritis. Therefore, the purpose of this study is test evaluate the effectiveness of these recent recommendations against current UK physical activity guidelines. AIMS - The study aims to investigate the role of walking in achieving a subjective improvement in symptomatic osteoarthritis of the knee/s. Furthermore, the study will investigate whether walking improves performance based tests which objectively assess physical function in participants with knee osteoarthritis. Null hypothesis to be tested: There is no difference in a 12 week intervention of walking 6,000 steps, per day, in improving pain and self reported physical function, compared to the current Department of Health physical activity guidelines. EXPERIMENTAL PROTOCOL AND METHODS - Participants will be recruited through poster advertisement and non-incentivised involvement. Potential participants will be sent a Patient Information Leaflet for the study and a Consent Form. Following consent, the participant will be screened by telephone to ensure participants meet the inclusion criteria and also to exclude participants who would not be eligible on their medical history and activity status alone. Eligible participants from screening will be invited for a formal assessment. The assessment will confirm that information given in the screening remains accurate and a focussed physical examination of the knee. Participants eligible at the end of end of assessment will be randomly allocation into the control and intervention group, both lasting 12 weeks. Block randomisation will be used and this will be prepared by an independent person. Participants, irrespective of their allocation, will complete the following questionnaires: KOOS (KOOS: Knee Injury and Osteoarthritis Outcome Score), IPAQ (IPAQ: International Physical Activity Questionnaire), VAS for knee pain (VAS: Visual Analogue Scale), OKS (OKS: Oxford Knee Score), SF36 (SF36: Short Form Health Survey) and WOMAC (WOMAC: Western Ontario and McMaster Universities Arthritis Index). The intervention group will be allocated a walking activity of 6,000 per day. Participants will be provided with a pedometer and diary so walking activity can be recorded and monitored. Weekly scores will be collected via telephone contact with the participant. The control group will be provided with the standard physical activity advice that participants would receive from their GP (GP: General Practitioner) regarding physical activity levels. Both groups will complete a further IPAQ questionnaire at the mid point of the study at 6 weeks to monitor physical activity levels. At 12 weeks at the end of study, all participants will repeat the initial questionnaires, KOOS, IPAQ, VAS, OKS, SF36 and WOMAC and the performance based tests. MEASUREABLE ENDPOINTS - Objective outcomes from performance based testing will be assessed, OARSI (OARSI: Osteoarthritis Research Society International) recommended physical function tests (6 minute walk test). Secondary outcomes: Pain, reported physical function in daily activities/sport/recreation, knee related quality of life measures from the above mentioned questionnaires and 4 other OARSI recommended functional tests (30sec chair stand test, 40m fast paced walk test, stair climb test and up and go test) in addition to age, sex, BMI (Body Mass Index), ethnicity and occupation. N.B. 6,000 steps roughly equates to 2.5 miles/4.3 km. This distance is based on 71 steps to cover 100m (Investigator's 100m pace). At a steady pace, on flat terrain, 1 mile can be covered in 15minutes. The distance and timing to complete 6,000 steps will vary between participants depending on their stride length and pace.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Pain, Arthritis, Gonarthritis, Sedentary, Knee Osteoarthritis, Motor Activity, Physical Activity
Keywords
Sedentary, Knee osteoarthritis, Knee pain, Gonarthritis, Arthritis, Walking, Pedometer, Physical Activity, Activities of Daily Function, Department of Health Physical Activity Guidelines, Improve pain, Decrease pain, Improve function, Increase function, Activity Monitoring, Monitoring, Ambulatory/instrumentation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Walking
Arm Type
Experimental
Arm Description
Randomised participants will be instructed to walk 6,000 steps per day and throughout the day for 12 weeks. Step counts will be monitored by an issued pedometer. A 12 week paper diary will be provided for daily recording of step counts.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Department of Health (United Kingdom) Physical Activity Guidelines flyer (current standard of care).
Intervention Type
Other
Intervention Name(s)
Walking
Intervention Description
The intervention group will be asked to walk a minimum 6,000 steps per day (7 days a week). Participants will be provided with a pedometer and daily diary to record step counts. Weekly scores will be collected via telephone contact. Followup questionnaires will be at 6, 12 and 24 months.
Intervention Type
Other
Intervention Name(s)
Department of Health Physical Activity Guidelines
Intervention Description
Adults should aim to be active daily. Over a week, activity should add up to at least 150 minutes (2½ hours) of moderate intensity activity in bouts of 10 minutes or more - one way to approach this is to do 30 minutes on at least 5 days a week. Alternatively, comparable benefits can be achieved through 75 minutes of vigorous intensity activity spread across the week or combinations of moderate and vigorous intensity activity. Adults should also undertake physical activity to improve muscle strength on at least two days a week. All adults should minimise the amount of time spent being sedentary (sitting) for extended periods.
Primary Outcome Measure Information:
Title
Objective assessment of participant aerobic capacity and physical function measured in the 6 Minute Walk Test
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Participant subjective opinion on their knee and associated symptoms measured by KOOS (Knee Injury and Osteoarthritis Score)
Time Frame
12 weeks
Title
Participant subjective opinion on their knee measured by WOMAC (Western Ontario and McMaster Universities Arthritis Index) Score
Time Frame
12 weeks
Title
Participant subjective opinion on their knee measured by OKS (Oxford Knee Score)
Time Frame
12 weeks
Title
Pain assessed VAS (Visual Analogue Scale) for knee pain
Time Frame
12 weeks
Title
Participant subjective opinion of their general and mental health assessed by SF36 (Short Form Health Survey)
Time Frame
12 weeks
Title
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - 30 second chair stand test
Time Frame
12 weeks
Title
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - 40 metre fast paced walk test
Time Frame
12 weeks
Title
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - stair climb test
Time Frame
12 weeks
Title
Objective assessment of participant physical function measured by OARSI (Osteoarthritis Research Society International) recommended functional tests for knee osteoarthritis - up and go test
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Following current NICE (The National Institute for Health Care Excellence) guidelines (United Kingdom) for diagnosing knee osteoarthritis: Anyone over the age of 45 with painful knee/s No morning stiffness or stiffness that lasts less than 30 minutes Exclusion Criteria: Exercise/activity > than current Department of Health physical activity guidelines Stiffness > 30mins in the morning Self-reported knee pathology (cruciate, meniscal, soft tissue, joint replacement) Cardiac disease - any: Acute coronary syndrome < 12 months Unexplained arrhythmia Angioplasty/cardiac surgery Congestive Cardiac Failure Valvular disease Cardiomyopathy Myocarditis Uncontrolled Hypertension Thrombolic events - any: Cerebrovascular accident/transient ischaemic attack last 12 months Deep vein thrombosis/pulmonary embolus last 6 months Asthma/Chronic Obstructive Pulmonary Disease Peak Expiratory Flow Rate < 300L/min/frequent exacerbations Anaemia Haemoglobin <90d/L Mental illness/learning disabilities/terminal illness Does not understand English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kimberley L Edwards, MMedSci PhD
Organizational Affiliation
University of Nottingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Nottingham
City
Nottingham
State/Province
Nottinghamshire
ZIP/Postal Code
NG7 2UH
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24923633
Citation
White DK, Tudor-Locke C, Zhang Y, Fielding R, LaValley M, Felson DT, Gross KD, Nevitt MC, Lewis CE, Torner J, Neogi T. Daily walking and the risk of incident functional limitation in knee osteoarthritis: an observational study. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1328-36. doi: 10.1002/acr.22362.
Results Reference
background
PubMed Identifier
18053188
Citation
Maddison R, Ni Mhurchu C, Jiang Y, Vander Hoorn S, Rodgers A, Lawes CM, Rush E. International Physical Activity Questionnaire (IPAQ) and New Zealand Physical Activity Questionnaire (NZPAQ): a doubly labelled water validation. Int J Behav Nutr Phys Act. 2007 Dec 3;4:62. doi: 10.1186/1479-5868-4-62.
Results Reference
background
PubMed Identifier
14613558
Citation
Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003 Nov 3;1:64. doi: 10.1186/1477-7525-1-64.
Results Reference
background
PubMed Identifier
12588583
Citation
Talbot LA, Gaines JM, Huynh TN, Metter EJ. A home-based pedometer-driven walking program to increase physical activity in older adults with osteoarthritis of the knee: a preliminary study. J Am Geriatr Soc. 2003 Mar;51(3):387-92. doi: 10.1046/j.1532-5415.2003.51113.x.
Results Reference
background
Links:
URL
http://www.nice.org.uk/guidance/ph41
Description
Nice.org.uk, (2012). Walking and cycling: local measures to promote walking and cycling as forms of travel or recreation | Guidance and guidelines

Learn more about this trial

An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study

We'll reach out to this number within 24 hrs